•
Mar 31, 2020

DaVita Q1 2020 Earnings Report

DaVita's Q1 2020 earnings report was released, highlighting the company's efforts to address the COVID-19 pandemic while maintaining high-quality patient care.

Key Takeaways

DaVita Inc. reported consolidated revenues of $2.841 billion, operating income of $465 million, and diluted earnings per share of $1.81 for the first quarter of 2020. The company also repurchased 4,052,298 shares of its common stock at an average cost of $74.81 per share.

Consolidated revenues reached $2.841 billion.

Operating income was $465 million, representing a 16.4% operating margin.

Diluted earnings per share from continuing operations stood at $1.81, with adjusted diluted earnings per share at $1.83.

Operating cash flow from continuing operations was $360 million, and free cash flow from continuing operations was $184 million.

Total Revenue
$2.84B
Previous year: $2.74B
+3.6%
EPS
$1.83
Previous year: $0.91
+101.1%
US Dialysis Treatments
7.51M
US Avg Treatments per day
96.82K
US Revenue per Treatment
$348
Gross Profit
$866M
Previous year: $778M
+11.3%
Cash and Equivalents
$1.38B
Previous year: $459M
+200.9%
Free Cash Flow
$184M
Previous year: -$57.6M
-419.6%
Total Assets
$17.6B
Previous year: $22.6B
-22.2%

DaVita

DaVita

DaVita Revenue by Segment

DaVita Revenue by Geographic Location

Forward Guidance

The company provided forward-looking measures that involve significant risks and uncertainties, particularly due to the widespread impact of the COVID-19 pandemic. Revenue is expected to be between $11.5 billion and $11.7 billion, and free cash flow from continuing operations is projected to be between $600 million and $800 million for 2020.

Revenue & Expenses

Visualization of income flow from segment revenue to net income